Thursday, February 26, 2026 | 03:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ERIS Lifesciences standalone net profit declines 9.01% in the September 2018 quarter

Capital Market

Sales rise 16.28% to Rs 237.07 crore

Net profit of ERIS Lifesciences declined 9.01% to Rs 83.98 crore in the quarter ended September 2018 as against Rs 92.30 crore during the previous quarter ended September 2017. Sales rose 16.28% to Rs 237.07 crore in the quarter ended September 2018 as against Rs 203.87 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales237.07203.87 16 OPM %40.9546.80 -PBDT97.07102.33 -5 PBT89.9997.83 -8 NP83.9892.30 -9

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 03 2018 | 5:24 PM IST

Explore News